Geron Corp. (GERN) intrinsic value & 10-year financials

Geron Corp. (GERN) has a Graham intrinsic value of $7.39 per share. At $1.17 on Oct 17, 2026, the stock trades 84% below that value.

Graham intrinsic value
$7.39
Share price (Oct 17, 2026)
$1.17
Price vs Graham value
84% below
Market cap
$780.0M
Revenue (FY2025)
—
Revenue growth (10-yr CAGR)
-37.2%
ROIC (10-yr avg)
-55.1%
Free cash flow (FY2025)
—

GERN 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 — -$83.5M -$0.13 — — -23.2%
FY2024 — -$174.6M -$0.27 -$219.3M — -59.4%
FY2023 $237.0K -$184.1M -$0.32 -$168.6M -81832.9% -113.8%
FY2022 $596.0K -$141.9M -$0.37 -$127.8M -23246.6% -126.9%
FY2021 $1.4M -$116.1M -$0.35 -$95.8M -8183.7% -61.8%
FY2020 $253.0K -$75.6M -$0.28 -$67.1M -30400.4% -42.8%
FY2019 $460.0K -$68.5M — -$44.2M -15762.0% -55.4%
FY2018 $1.1M -$27.0M — -$21.0M -2914.9% -19.2%
FY2017 $1.1M -$27.9M -$0.18 — -2746.9% -24.7%
FY2016 $6.2M -$29.5M -$0.19 -$18.4M -497.3% -24.1%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

GERON CORP revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

GERON CORP has historically struggled to out-earn its cost of capital, averaging just -55.1% ROIC.

GERON CORP has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, GERON CORP is modeled at -37.2% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $7.39 per share.

GERN stock: frequently asked questions

What is the intrinsic value of Geron Corp. (GERN) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a -37.2% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, GERN's intrinsic value is about $7.39 per share.

Is GERN stock undervalued?

At $1.17 (close on Oct 17, 2026), GERN trades 84% below its Graham value of $7.39. On Graham's terms that leaves a margin of safety. A formula is a starting point for research, not a recommendation.

What is GERN's return on invested capital?

Average ROIC over the last 10 fiscal years was -55.1%, and average return on equity was -57.3%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this GERN data come from?

From Geron Corp.'s annual 10-K filings on SEC EDGAR. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar pharmaceutical preparations stocks